Prescription drug · UNAPPROVED DRUG OTHER
Phenobarbital NDC 13811-304
Phenobarbital 16.2 mg/1 · Tablet · Oral · Trigen Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 13811-304-10 | 13811030410 | 100 TABLET in 1 BOTTLE, PLASTIC (13811-304-10)Marketed from Apr 1, 2025 | |
| 13811-304-52 | 13811030452 | 1000 TABLET in 1 BOTTLE, PLASTIC (13811-304-52)Marketed from Apr 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Phenobarbital
- Generic name (nonproprietary)
- phenobarbital
- Active ingredients
- Phenobarbital — 16.2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Trigen Laboratories, LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Identifiers
- Product ID 13811-304_e0527225-8681-4a9c-8b5c-2681579f4115SPL ID e0527225-8681-4a9c-8b5c-2681579f4115SPL set ID 5d1f0f48-06d9-4408-b9a2-60d7a09d942fRxCUI 198086, 199164, 199167, 199168UNII YQE403BP4DUPC 0313811304107, 0313811306521, 0313811305104, 0313811305524, 0313811307108, 0373877307528, 0313811306101
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N413811030410followed by a unit qualifier and the quantityPackage 13811-0304-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE 1. Sedative 2. Anticonvulsant – For the treatment of generalized and partial seizures.
Excerpt only. Read the full label for complete information.